Oxybutynin ER better value than tolterodine IR for overactive bladder

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.447, 2004-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxybutynin ER vs tolterodine for overactive bladder

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

By Guest J.F.   Abegunde D.   Ruiz F.J.  

Clinical Drug Investigation, Vol. 24, Iss. 6, 2004-01 ,pp. : 305-321

Adis International

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder

By Salvatore Stefano   Serati Maurizio   Bolis Pierfrancesco  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1249-1255

Informa Healthcare

Access to resources Recommend Favorite

Transdermal Oxybutynin: For Overactive Bladder

By Bang L.M.   Easthope S.E.   Perry C.M.  

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 857-864

Adis International

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder: a review

By Rovner Eric S  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite